Tissue Regenix Group (LON:TRX) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened

Tissue Regenix Group plc (LON:TRXGet Free Report)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 58.87 ($0.73) and traded as low as GBX 58 ($0.72). Tissue Regenix Group shares last traded at GBX 58.02 ($0.72), with a volume of 61,040 shares.

Tissue Regenix Group Stock Performance

The business’s fifty day moving average price is GBX 57.99 and its two-hundred day moving average price is GBX 58.87. The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74. The stock has a market capitalization of £41.33 million, a P/E ratio of -5,802.00 and a beta of 1.61.

About Tissue Regenix Group

(Get Free Report)

Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.

Recommended Stories

Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.